The prevalence of cardiac arrhythmia increases within a continuously aging population. This is illustrated by the projection of a 2.5-fold increase in the number of cases of atrial fibrillation (AF) in the United States by 2050. Approaches to arrhythmia management have changed considerably in recent years; this is, in part, related to the better understanding of effects of the existing drug therapy in patients with arrhythmia, and the advances of catheter ablation and complex device therapies for selected older patients.
In this review, we have broadly classified arrhythmias into brady- and tachyarrhythmias (AF, paroxysmal supraventricular tachycardias, and ventricular arrhythmias) and followed by highlighting the contemporary therapies for these arrhythmias in older adults.
Key words: aging, arrhythmia, drug, ablation, devices.
Copyright © 2011-2020 Health Plexus Ltd. All rights reserved.